- Projects, Research

A lack of iodine in the diet could threaten brain development in children

Scientists warn that a widespread lack of iodine threatens brain development in children.   Iodine insufficiency is one of easiest public health problems to solve, even though it affects so many people worldwide.  According to experts, the key to preventing iodine insufficiency is consumption of adequate amounts in a sustained and continued way.  The " Krakow Declaration on Iodine" created by the EUthyroid Project calls on those responsible for European policy to support measures to eliminate iodine insufficiency.

- Research

Two new papers describe more about the relationship between cancer cells and the immune system

The Innate Immunity Group, led by Maria Rosa Sarrias has published two papers on their work on how cancer cells subtly retrain the body's immune system and subvert its natural defences.  In this case the group has worked on liver cancer, in conjunction with the Childhood Liver Cancer Group (C-Log), Marga Sala (Hepatology Unit, Department of Gastroenterology, Germans Trias Hospital) and doctors from a large number of hospitals, but they believe the mechanism may be important for the prognosis of many different cancers.

- Research

Telomere shortening is not a factor in the progression of cardiac insufficiency

Researchers from the Heart Disease Research Group at the Germans Trias I Pujol Research Institute (IGTP) and researchers from the Spanish Biomedical Research Network for Cardiovascular Disease (CIBERCV) have analysed  the degree of shortening of telomeres and its correlation with  progression of cardiac insufficiency (CI) over a year. The results published in Journal of Translational Medicine indicate that telomere shortening in monocytes is probably not a biomarker for the progression of CI

- Research

IGTP researchers confirm the feasibility of immunotherapy in cells of the immune system of patients with type 1 diabetes

Researchers from the Immunology of Diabetes research group of the Germans Trias i Pujol Research Institute (IGTP) have confirmed, in human cells, that liposomes designed as immunotherapy for type 1 diabetes (T1D) are a valid strategy to arrest the autoimmune attack characteristic of this disease. They have done so in a preclinical study demonstrating the tolerogenic effect of these liposomes on cells of the immune system of patients with T1D. The results have been published in the journal Frontiers in Immunology.

- Campus Can Ruti, Research

Julia García Prado, new IGTP Scientific Director

Dr. García Prado, leader of the Viral Immune Evasion and Vacciones (VIRIEVAC) at the IrsiCaixa AIDS Research Institute will combine the new position with the leadership of her group, focused on the design of new strategies against HIV. Manel Puig, General Director of the IGTP, has presented the new organizational chart during the presentation of the Research Agenda 2018, together with the new challenges for the coming years.